EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Optimizing mitochondria function in immune cells: implications for cancer immunotherapy

Huiyu Li, Wenyi Jin, Junhong Liu, Yundong Zhou, Xiaoli Shan, Yubiao Zhang, Yongliang Kou, Chunyan Deng, Cheng Jin, Junjie Kuang, Yui-Leung Lau, João Conde und 2 weitere

Trends in Cancer · 2025-12 · 11 (12) · 1170-1184

DOI: 10.1016/j.trecan.2025.08.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-12. Verfasst von Huiyu Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong. Hauptthemen laut MEDLINE: Neoplasms, Mitochondria, Immunotherapy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 107 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) imposes profound metabolic and functional constraints on immune cells, with mitochondrial dysfunction emerging as a pivotal driver of immunosuppression. While mitochondrial metabolism is well recognized for its role in energy production and cellular homeostasis, its dynamic regulation of immune cell activation, differentiation, and exhaustion within the TME remains underexplored. In this review we summarize insights into how TME stressors such as hypoxia, nutrient competition, and metabolic byproducts subvert mitochondrial dynamics, redox balance, and mitochondrial DNA (mtDNA) signaling in T cells, natural killer (NK) cells, and macrophages, thereby directly impairing their antitumor efficacy. We emphasize that the restoration of mitochondrial fitness in immune cells, achieved by targeting metabolites in the TME and mitochondrial quality control, represents a pivotal axis for adoptive cell therapies (ACTs) and TME reprogramming.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMitochondriaImmunotherapyHumansTumor MicroenvironmentAnimalsKiller Cells, NaturalT-LymphocytesImmunotherapy, AdoptiveMacrophagesMitochondrial DynamicsEnergy MetabolismDNA, Mitochondrial

Stichwörter der Autor:innen

ROSchimeric antigen receptor (CAR)metabolismmitochondriatumor immunotherapy

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong.
  • Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Geriatrics, Weifang People's Hospital, Weifang, China.
  • The Second Department of Oncology, Cancer Center, Huizhou First Hospital, Huizhou, China.
  • The Third Department of Geriatrics, Weifang People's Hospital, Weifang, China.
  • Department of Pathology, Weifang People's Hospital, Weifang, China.

Zitieren

APA

Li, H., Jin, W., Liu, J., Zhou, Y., Shan, X., Zhang, Y., Kou, Y., Deng, C., Jin, C., Kuang, J., Lau, Y. L., Conde, J., Huang, B., & Lin, Q. (2025). Optimizing mitochondria function in immune cells: implications for cancer immunotherapy. Trends in Cancer, 11(12), 1170-1184. https://doi.org/10.1016/j.trecan.2025.08.006

Vancouver

Li H, Jin W, Liu J, Zhou Y, Shan X, Zhang Y, et al. Optimizing mitochondria function in immune cells: implications for cancer immunotherapy. Trends in Cancer. 2025;11(12):1170-1184. doi:10.1016/j.trecan.2025.08.006

BibTeX
@article{Li2025,
  author = {Li, Huiyu and Jin, Wenyi and Liu, Junhong and Zhou, Yundong and Shan, Xiaoli and Zhang, Yubiao and Kou, Yongliang and Deng, Chunyan and Jin, Cheng and Kuang, Junjie and Lau, Yui-Leung and Conde, João and Huang, Baozhen and Lin, Queran},
  title = {Optimizing mitochondria function in immune cells: implications for cancer immunotherapy},
  journal = {Trends in Cancer},
  year = {2025},
  volume = {11},
  number = {12},
  pages = {1170--1184},
  doi = {10.1016/j.trecan.2025.08.006}
}
Kostenlos starten →